The European Organisation for Research and Treatment of Cancer ( EORTC ) and Gruppo Italiano Malattie Ematologiche dell ' Adulto ( GIMEMA ) Leukemia Groups conducted a randomized trial ( AML-@ ; Combination Chemotherapy , Stem Cell Transplant and Interleukin-@ in Treating Patients With Acute Myeloid Leukemia ) in @,@ newly diagnosed patients with AML , age @ to @ years , comparing remission induction treatment containing daunorubicin , etoposide , and either standard-dose ( SD ) cytarabine ( @ mg/m ( @ ) per day by continuous infusion for @ days ) or high-dose ( HD ) cytarabine ( @,@ mg/m ( @ ) every @ hours by @-hour infusion on days @ , @ , @ , and @ ) .